


























![]()
Spyre Therapeutics, Inc. (SYRE) Discusses SPY001 Part A Induction Topline Results From SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis April 13, 2026 8:00 AM EDT
Company Participants
Eric McIntyre - Vice President of Finance & Investor Relations
Cameron Turtle - CEO & Director
Deanna Nguyen - Senior Vice President of Clinical Development
Conference Call Participants
Samuel Slutsky - LifeSci Capital, LLC, Research Division
Tyler Van Buren - TD Cowen, Research Division
Akash Tewari - Jefferies LLC, Research Division
Alexander Thompson - Stifel, Nicolaus & Company, Incorporated, Research Division
Min Lee - Guggenheim Securities, LLC, Research Division
Thomas Smith - Leerink Partners LLC, Research Division
Debanjana Chatterjee - JonesTrading Institutional Services, LLC, Research Division
David Nierengarten - Wedbush Securities Inc., Research Division
Julian Harrison - BTIG, LLC, Research Division
Kyuwon Choi - Goldman Sachs Group, Inc., Research Division
Yanan Zhu - Wells Fargo Securities, LLC, Research Division
David Hoang - Deutsche Bank AG, Research Division
Brandon Frith - Wolfe Research, LLC
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Spyre Therapeutics SPY001 Part A Induction Topline Results Conference Call. [Operator Instructions] Please note that today's conference is being recorded. I will now hand the conference over to your speaker host for today, Eric McIntyre, SVP of Investor Relations. Please go ahead.
Eric McIntyre
Vice President of Finance & Investor Relations
Thank you, Olivia, and thank you all for joining. We're thrilled to be speaking with you this morning. As you saw today, we issued a press release outlining positive topline induction results from Part A of our SKYLINE trial of 001 for the treatment of moderately to severely active ulcerative colitis.
Press release and slides that we will be using today during our call are available on the Investors section of our website. I would remind everyone that during this call, we'll be making forward-looking statements related to our current expectations
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。